XNYS
CTVA
Market cap9.25bUSD
Oct 08, Last price
13.75USD
1D
-4.84%
1Q
6.96%
IPO
218.59%
Name
Corteva Inc
Chart & performance
P/E
8.41
P/S
0.53
EPS
1.64
Div yield, %
5.06%
Shrs. gr., 5y
-1.93%
Rev. gr., 5y
4.12%
Revenues
17.40b
+2.92%
Net income
1.09b
+20.62%
CFO
3.41b
+58.79%
Dividend
Sep 01, 20260.18 USD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Corteva, Inc. engages in the provision of seed and crop protection solutions. It focuses on the agriculture industry and food supply. It operates through the Seed and Crop Protection segments. The Seed segment is involved in the development and supply of advanced germplasm and traits that produce yield for farms. The Crop Protection segment includes the global agricultural input industry with products for weeds, insects, other pests, and diseases protection, through nitrogen management and seed-applied technologies. The company was founded in 1802 and is headquartered in Indianapolis, IN.
Related entities
Subsidiaries (5)
CORTEVA AGRISCIENCE LLC
CORTEVA AGRISCIENCE SERVICES INDIA PRIVATE LIMITED
DUPONT CAPITAL MANAGEMENT CORPORATION
PIONEER OVERSEAS CORPORATION
PIONEER HI-BRED ITALIA SEMENTI S.R.L.
Key people
Cornel B. Fuerer
Senior Vice President, General Counsel, Secretary
Brian Titus
Principal Accounting Officer, Vice President, Controller
Chief Executive Officer, Director
Lamberto Andreotti
Independent Director
Independent Chairman of the Board
Patrick J. Ward
Independent Director
Legal address
C/O THE CORPORATION TRUST COMPANY
CORPORATION TRUST CENTER 1209 ORANGE ST
WILMINGTON, DE 19801
US
CORPORATION TRUST CENTER 1209 ORANGE ST
WILMINGTON, DE 19801
US
Headquarters
974 Centre Road
Wilmington, DE 19805
US
Wilmington, DE 19805
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||